Literature DB >> 3291548

Treatment versus no treatment in chronic open angle glaucoma.

C Holmin1, W Thorburn, C E Krakau.   

Abstract

In a controlled randomized study 15 patients (20 eyes) with chronic open angle glaucoma and visual field defects were followed by greater than 1 year, 12 of them were followed for 3 years. Half of the group were untreated controls, the other half treated with pressure reducing medical therapy. At least 5 consecutive computerized visual fields were recorded (COMPETER) on each eye, and the linear regression coefficient was calculated. With the reservation for uncontrolled compliance no significant difference in the line of favourable effect of pressure reduction could be spotted, in spite of an average pressure reduction in the treated group of 4 mmHg. More important than this result, which is open to criticism for the smallness of the material, uncontrolled compliance etc, is the lesson that a randomized experiment with treated and non-treated glaucoma cases carried out in accordance with the Helsingfors convention is hardly feasible.

Entities:  

Mesh:

Year:  1988        PMID: 3291548     DOI: 10.1111/j.1755-3768.1988.tb04006.x

Source DB:  PubMed          Journal:  Acta Ophthalmol (Copenh)        ISSN: 0001-639X


  13 in total

1.  The effect of topical glaucoma medications evaluated by perimetry.

Authors:  J-C Lin; F Samuel; L J Katz; G L Spaeth; J Hoop; L B Cantor
Journal:  Br J Ophthalmol       Date:  2003-06       Impact factor: 4.638

Review 2.  Low tension glaucoma--its place in modern glaucoma practice.

Authors:  R A Hitchings
Journal:  Br J Ophthalmol       Date:  1992-08       Impact factor: 4.638

3.  Improved retinal function after trabeculectomy in glaucoma patients.

Authors:  Elisabeth Wittström; Patrik Schatz; Monica Lövestam-Adrian; Vesna Ponjavic; Anders Bergström; Sten Andréasson
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-10-29       Impact factor: 3.117

Review 4.  Treatment of ocular hypertension and open angle glaucoma: meta-analysis of randomised controlled trials.

Authors:  Philip C Maier; Jens Funk; Guido Schwarzer; Gerd Antes; Yngve T Falck-Ytter
Journal:  BMJ       Date:  2005-07-01

5.  The sight test fee. Effectiveness of treatment for glaucoma remains unproved.

Authors:  L Clearkin
Journal:  BMJ       Date:  1994-11-19

Review 6.  Medical interventions for primary open angle glaucoma and ocular hypertension.

Authors:  C Vass; C Hirn; T Sycha; O Findl; P Bauer; L Schmetterer
Journal:  Cochrane Database Syst Rev       Date:  2007-10-17

7.  Effect of IOP on the visual field in ocuLar hypertension and glaucoma.

Authors:  A Heijl
Journal:  Int Ophthalmol       Date:  1989-01       Impact factor: 2.031

8.  Repeatability of the Novel Intraocular Pressure Measurement From Corvis ST.

Authors:  Masato Matsuura; Hiroshi Murata; Yuri Fujino; Mieko Yanagisawa; Yoshitaka Nakao; Shunsuke Nakakura; Yoshiaki Kiuchi; Ryo Asaoka
Journal:  Transl Vis Sci Technol       Date:  2019-06-24       Impact factor: 3.283

9.  Association between visual field damage and corneal structural parameters.

Authors:  Alexandru Lavric; Valentin Popa; Hidenori Takahashi; Rossen M Hazarbassanov; Siamak Yousefi
Journal:  Sci Rep       Date:  2021-05-24       Impact factor: 4.379

10.  The Relationship between Corvis ST Tonometry and Ocular Response Analyzer Measurements in Eyes with Glaucoma.

Authors:  Masato Matsuura; Kazunori Hirasawa; Hiroshi Murata; Mieko Yanagisawa; Yoshitaka Nakao; Shunsuke Nakakura; Yoshiaki Kiuchi; Ryo Asaoka
Journal:  PLoS One       Date:  2016-08-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.